Bone Diseases: Clinical Trials

685 trials for Bone Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

412 completed, 95 unknown, 59 terminated, 45 recruiting. 685 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4685Completed 412, Unknown 95, Terminated 59, Recruiting 45, Withdrawn 28, Not yet recruiting 23, Active not recruiting 18, Enrolling by invitation 4, Suspended 1

Follow Bone Diseases: new trials by email Literature Review of Bone Diseases trials Research Report on Bone Diseases

Trials (filtered) newest first · largest first

All 685 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD
Romosozumab, Zoledronic Acid 5 MG in 5 ML Injection, Calcium 500 mg and Vitamin D3 800 IU - Osteoporosis in Post-menopausal Women
Phase 4Not yet recruitingSahlgrenska University Hospital2162027-01-112026-08-19
Romosozumab and Denosumab Combination Therapy for Osteoporosis
Romosozumab, Romosozumab and Denosumab - Postmenopausal Osteoporosis
Phase 4Not yet recruitingMassachusetts General Hospital1002027-01-012026-11-03
Remimazolam vs Propofol for Motor and Somatosensory Evoked Potentials in Spinal Tumor Surgery
Remimazolam, Propofol - Spinal Cord Neoplasms, Spinal Neoplasms
Phase 4Not yet recruitingBeijing Tsinghua Chang Gung Hospital1902027-01-012026-10-28
A Pragmatic Trial of Interleukin-17 Inhibition Versus Janus Kinase Inhibition After Tumor Necrosis Factor-alpha Inhibitor Failure in Axial Spondyloarthritis
Secukinumab (IL-17i ), Upadacitinib (JAKi) - Axial Spondyloarthritis (AxSpA)
Phase 4Not yet recruitingThe University of Texas Health Science Center, Houston402026-11-012026-10-14
Emerging Indications for Hyperbaric Oxygen Treatment
Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis
Phase 4Not yet recruitingJay C. Buckey Jr.1002026-11-012026-09-09
Ivarmacitinib With or Without Celecoxib for Ankylosing Spondylitis
Ivarmacitinib with celecoxib, Ivarmacitinib Monotherapy - Ankylosing Spondylitis (AS)
Phase 4Not yet recruitingPeking University Third Hospital1382026-10-252026-10-27
E-Type - Early Wear of Polyethylene Liners Used in DMC
Total Hip Arthroplasty - Osteoarthritis, Osteonecrosis
Phase 4RecruitingUppsala University402026-10-082026-10-09
Comparing Three Epidural Steroid Injection Approaches for Lumbar Radicular Pain
High-Volume Parasagittal Interlaminar Epidural Steroid Injection, Low-Volume Parasagittal Interlaminar Epidural Steroid Injection, Transforaminal epidural steroid injection - Lumbar Disc Herniation, Lumbosacral Radiculopathy
Phase 4Not yet recruitingBenha University992026-10-012026-09-14
Romosozumab Versus Denosumab In Glucocorticoid-induced Osteoporosis: An Extended Observation Of a Clinical Trial at 6 Years
Romosozumab, Denosumab - Glucocorticoid-Associated Osteopenia and Osteoporosis
Phase 4Not yet recruitingTuen Mun Hospital542026-09-012026-08-12
A Clinical Trial of Antiplatelets in Psoriasis
Aspirin, Clopidogrel, Placebo - Psoriasis (PsO), Psoriatic Arthritis (PsA)
Phase 4Not yet recruitingNYU Langone Health602026-09-012026-08-05
The Comparison of Ibandronate and Zoledronic Acid After Denosumab Discontinuation
Ibandronate IV, Zoledronic acid IV - Postmenopausal Osteoporosis, Postmenopausal Osteopenia
Phase 4RecruitingNational Taiwan University Hospital522026-08-202026-08-25
A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
Breast Milk Sample Collection, Guselkumab - Psoriasis, Colitis, Ulcerative
Phase 4RecruitingJanssen Research & Development, LLC102026-08-072026-11-03
Influence of Lidocaine Infusion on Motor Evoked Potential Thresholds
Lidocaine in Saline, Normal saline - Spinal Disease, Anesthesia
Phase 4Not yet recruitingDartmouth-Hitchcock Medical Center442026-08-012025-11-24
Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease
Apixaban - Venous Thromboembolism (VTE), Deep Vein Thrombosis (DVT)
Phase 4Not yet recruitingJames Bayley502026-08-012026-07-20
Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study)
triamcinolone acetonide (Kenalog), Celestone Soluspan 6Mg/Ml Suspension for Injection, Depo-Medrol 40Mg/Ml Suspension for Injection - Back Pain Lower Back, Neck Pain
Phase 4RecruitingIgor Wilderman. MD5002026-07-302026-08-13
Osteoporotic Fracture and Lidocaine Plaster 5% for Neuropathic Pain preventioN
Lidocaine 5% medicated plaster - Osteoporotic Vertebral Fracture, Neuropathic Pain
Phase 4Not yet recruitingUniversity Hospital, Clermont-Ferrand302026-07-012026-07-08
Return to Activity After Surgery for Lumbar Disc Herniation
Postoperative therapy - Lumbar Disc Herniation Surgery, Disc Herniation
Phase 4Not yet recruitingIntrinsic Therapeutics1202026-06-302026-06-25
Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
Deucravacitinib, Placebo - Psoriatic Arthritis (PsA)
Phase 4RecruitingUniversity of Texas Southwestern Medical Center1282026-06-162026-09-01
Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis
Upadacitinib 15 MG [Rinvoq] - Axial Spondylarthritis (axSpA)
Phase 4Not yet recruitingCARE ARTHRITIS LTD.2002026-05-012026-02-06
Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial
GLP-1 agonists, Nutrition Counseling - Psoriatic Arthritis (PsA)
Phase 4RecruitingMedical College of Wisconsin222026-05-012026-11-05

Showing 20 of 685. Sign in to see all of them.

Narrower conditions

Osteoporosis (166)  ·  Bone Diseases, Metabolic (72)  ·  Osteoporosis, Postmenopausal (72)  ·  Spondylitis, Ankylosing (59)  ·  Arthritis, Psoriatic (48)  ·  Spinal Stenosis (37)  ·  Arthritis, Rheumatoid (32)  ·  Intervertebral Disc Displacement (32)  ·  Dwarfism, Pituitary (30)  ·  Osteonecrosis (28)  ·  Acromegaly (25)  ·  Osteoarthritis (25)  ·  Scoliosis (22)  ·  Spondylarthritis (22)  ·  Spinal Diseases (19)

Broader conditions

Musculoskeletal Diseases (684)  ·  Nutritional and Metabolic Diseases (283)  ·  Metabolic Diseases (281)  ·  Spinal Diseases (228)  ·  Bone Diseases, Metabolic (201)  ·  Joint Diseases (172)  ·  Arthritis (166)  ·  Pathological Conditions, Signs and Symptoms (164)  ·  Spondylitis (133)  ·  Spondylarthritis (111)  ·  Spondylarthropathies (111)  ·  Pathologic Processes (102)  ·  Skin and Connective Tissue Diseases (99)  ·  Nervous System Diseases (92)

Interventions

Denosumab (41)  ·  Zoledronic Acid (40)  ·  Teriparatide (35)  ·  Alendronate (32)  ·  Etanercept (32)  ·  Risedronic Acid (28)  ·  Vitamin D (25)  ·  Ibandronic Acid (24)  ·  Adalimumab (23)  ·  Sodium Chloride (22)  ·  Calcium (18)  ·  Cholecalciferol (16)  ·  Infliximab (16)  ·  Saline Solution (16)  ·  Human Growth Hormone (14)

Sponsors

Eli Lilly and Company (19)  ·  Hoffmann-La Roche (17)  ·  Novartis Pharmaceuticals (17)  ·  DePuy International (15)  ·  Pfizer (13)  ·  Massachusetts General Hospital (12)  ·  Columbia University (9)  ·  National Taiwan University Hospital (9)  ·  Sanofi (9)  ·  Sun Yat-sen University (9)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (9)  ·  Amgen (8)  ·  Tuen Mun Hospital (8)  ·  Charite University, Berlin, Germany (7)  ·  Merck Sharp & Dohme LLC (7)

Countries

United States (211)  ·  China (60)  ·  Germany (56)  ·  France (46)  ·  Canada (44)  ·  Spain (44)  ·  Denmark (41)  ·  United Kingdom (41)  ·  Italy (35)  ·  Poland (34)  ·  South Korea (29)  ·  Netherlands (26)  ·  Sweden (23)  ·  Australia (22)  ·  Brazil (22)

Top investigators

Benjamin Leder, MD (4)  ·  Anne Kenny, MD (3)  ·  Chi Chiu Mok, MD, FRCP (3)  ·  Hannu T Aro, MD, PhD (3)  ·  James N. Weinstein, DO, MS (3)  ·  Jieruo Gu, Prof (3)

Results publications

PMID 22048651, PMID 34231877, PMID 11138687, PMID 15613435, PMID 15827109, PMID 16018754, PMID 33813753, PMID 35478046, PMID 36088628, PMID 38488976, PMID 38979716, PMID 39527056, PMID 10469005, PMID 10690849, PMID 10999798, PMID 11063900, PMID 11181474, PMID 11397887, PMID 11514795, PMID 11788630, PMID 11840097, PMID 12177541, PMID 12843148, PMID 12925248, PMID 1421796, PMID 14742657, PMID 14764779, PMID 15070920, PMID 15080776, PMID 15080778, PMID 15099442, PMID 15362960, PMID 15886238, PMID 15886256, PMID 15915040, PMID 15995108, PMID 16306743, PMID 16373932, PMID 16449332, PMID 16487447, PMID 16490909, PMID 16537687, PMID 16757774, PMID 16918950, PMID 17119140, PMID 17119141, PMID 17182297, PMID 17202417, PMID 17259801, PMID 17355365

NIH funding

2015 (9), 2005 (6), 2016 (5), 2018 (4), 2023 (4), 2014 (3), 2025 (3), U01AR045444 (3), 2008 (2), 2017 (2), 2009 (1), K23DA020681 (1), K23HL152013 (1), P30AG024827 (1), R01AG018887 (1)